Kintara Therapeutics Inc

NASDAQ:KTRA  
1.39
+0.02 (+1.84%)
Earnings Announcements

Kintara Therapeutics posts Q1 Loss Per Share $1.33

Published: 11/13/2020 13:18 GMT
Kintara Therapeutics Inc (KTRA) - Q1 Loss per Share $1.33.
Qtrly EPS $1.33.
at September 30, 2020, Company Had Cash and Cash Equivalents of Approximately $22.6 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.13

More details on our Analysts Page.